Effect of Hepatic Stimulator Substance Administration on Tissue Regeneration Due to Thioacetamide-Induced Liver Injury in Rats

References

• Kirsch RE, Cohen CD, Saunders SJ, Van Hoorn-Hickman, Terblanche J, Alp M. Acute liver failure. In: Wright R, Millward-Sadler GH, Alberti KGMM, Karran S, editors. Liver and biliary disease. 3rd ed. London: Bailliere Tindall/WB Saunders; 1985. p. 659–76.
   Google Scholar
• Fleig WE. Liver specific growth factors. Scand J Gastroenterol 1988;23 Suppl 151:31–6.
   PubMedGoogle Scholar
• LaBrecque DR, Pesh LA. Preparation and partial characterization of hepatic regenerative stimulator substance (SS) from rat liver. J Physiol 1975;248:273–84.
   PubMed Web of Science ®Google Scholar
• Fleig WE, Lehmann H, Wagner H, Hoss G, Ditschuneit H. Hepatic regenerative stimulator substance in the rabbit. Relation to liver regeneration after partial hepatectomy. J Hepatol 1986; 3:19–26.
   Google Scholar
• Francavilla A, Ove P, Polimeno L, Coetzee M, Makowka L, Rose J, et al. Extraction and partial purification of hepatic stimulatory substance in rats, mice and dogs. Cancer Res 1987;47:5600–5.
   PubMed Web of Science ®Google Scholar
• Mao-Hua M, Wei A, Bao-Hong Z, Qing S, De-Zheng G. Hepatic stimulator substance protects against acute liver failure induced by carbon tetrachloride poisoning in mice. Hepatology 1993; 17:638–44.
   Google Scholar
• Zhiqiang Y, Weisong Y, Wenbin Z, Yong C, Yongxing Z. Hepatic stimulator substance from human fetal liver for treatment of experimental hepatic failure. Chin Med J 1992; 105:676–83.
   Google Scholar
• Theocharis SE, Margeli AP, Spiliopoulou C, Skaltsas S, Kittas C, Koutselinis A. Hepatic stimulator substance administration enhances the regenerative capacity of hepatocytes in cadmium-pretreated partially hepatectomized rats. Dig Dis Sci 1996;41: 1475–80.
   PubMedGoogle Scholar
• Margeli A, Theocharis S, Spiliopoulou C, Horti M, Koutselinis A. Hepatic stimulator substance administration affects cadmium-induced hepatotoxicity in the rat. Int Hepatol Commun 1996;5:128–34.
   Google Scholar
• Fitzhugh OG, Nelson AA. Liver tumors in rats fed thiourea or thioacetamide. Science 1948;108:626–8.
   PubMed Web of Science ®Google Scholar
• Trennery PN, Waring RH. Early changes in thioacetamide-induced liver damage. Toxicol Lett 1983;19:299–307.
   PubMedGoogle Scholar
• Chanda S, Mehendale HM. Role of nutritional fatty acid and L-carnitine in the final outcome of thioacetamide hepatotoxicity. FASEB J 1994;8:1061–8.
   PubMedGoogle Scholar
• Mangipudy RS, Chanda S, Mehendale HM. Tissue repair response as a function of dose in thioacetamide hepatotoxicity. Environ Health Perspect 1995;103:260–7.
   Google Scholar
• Reddy J, Chiga M, Svoboda D. Initiation of the division cycle of rat hepatocytes following a single injection of thioacetamide. Lab Invest 1969;20:405–11.
   Google Scholar
• Munro HN, Fleck A. Recent developments in the measurement of nucleic acids in biological materials. Analyst 1966;91:78–88.
   PubMed Web of Science ®Google Scholar
• Richards GM. Modifications of the diphenylamine reaction giving increased sensitivity and simplicity in the estimation of DNA. Anal Biochem 1974;57:369–76.
   PubMed Web of Science ®Google Scholar
• Kahn D, Svanas G, Eagon P, Makowka L, Podesta L, Chapchap P, et al. Effect of an antiandrogenic H2 receptor antagonist on hepatic regeneration in rats. J Lab Clin Med 1988;112:232–9.
   PubMedGoogle Scholar
• Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem 1951; 193:265–75.
   PubMed Web of Science ®Google Scholar
• International Federation of Clinical Chemistry: Committee on Standards, Enzyme Panel Clin Chem 1978;24:720–1.
   Google Scholar
• LaBrecque DR, Feigenbaum A, Bachur NR. Diurnal rhythm: effects on hepatic regeneration and hepatic regenerative stimulator substance. Science 1978;199:1082–4.
   Google Scholar
• LaBrecque DR, Steele G, Fogerty S, Wilson M, Barton J. Purification and physical-chemical characterization of hepatic stimulator substance. Hepatology 1988;7:100–6.
   Google Scholar
• LaBrecque DR, Bachur NR. Hepatic stimulator substance: physicochemical characteristics and specificity. Am J Physiol 1982;242:G281–8.
   Google Scholar
• Higgins GM, Anderson RM. Experimental pathology of the liver. Restoration of the liver of the white rat following partial surgical removal. Arch Pathol 1931;12:186–201.
   Google Scholar
• Theocharis SE, Agapitos E, Margeli AP, Goutas N, Kittas C, Davaris P. Effect of two forms of granulocyte-colony-stimulating factor on hepatic regeneration after 70% partial hepatectomy in rats. Clin Sci 1997;92:315–20.
   PubMedGoogle Scholar
• Porter WR, Gudzinowicz MJ, Neal RA. Thioacetamide-induced hepatic necrosis. II. Pharmacokinetics of thioacetamide and thioacetamide S-oxide in the rat. J Pharmacol Exp Ther 1979; 208:386–91.
   Google Scholar
• Wei A, Mao-Hua M. A study of the protective mechanism of hepatic stimulator substance against experimental acute liver failure in mice. Acta Physiol Sinica 1992;44:54–61.
   PubMedGoogle Scholar
• Fleig WE, Hoss G. Partial purification of rat stimulator substance and characterization of its action on hepatoma cells and normal hepatocytes. Hepatology 1989;9:240–8.
   PubMed Web of Science ®Google Scholar
• Zhiqiang Y, Weisong Y, Wenbin Z, Yong C, Fengyi Y. Human hepatic regenerative stimulator substance: partial purification and biological characterization of hepatic stimulator substance from human fetal liver cells. Hepatology 1990;12:1144–51.
   Google Scholar
• Zhiqiang Y, Weisong Y, Benfu C, Peng S, Wenbin Z, Yong C. Purification and characterization of human hepatic stimulator substance. Chin Med J 1993;106:527–32.
   PubMedGoogle Scholar
• Francavilla A, Azzarone A, Carrieri G, Scotti-Foglieni C, Zeng Q, Cillo U, et al. Effect on the canine Eck fistula liver of intraportal TGF-β alone or with hepatic growth factors. Hepatology 1992;16:1267–70.
   Google Scholar
• Francavilla A, Azzarone A, Carrieri G, Cillo U, Van Thiel D, Subbottin V, et al. Administration of hepatic stimulatory substance alone or with other liver growth factors does not ameliorate acetaminophen-induced liver failure. Hepatology 1993;17:429–33.
   PubMedGoogle Scholar
• Guillaume D, Clamon L, LaBrecque DR. Hepatic stimulator substance (HSS) stimulates phosphoinositol hydrolysis. Hepatology 1996;24\(No 4, Pt.2) Suppl:362A.
   Google Scholar
• Margeli A, Theocharis S, Skaltsas S, Skopelitou A, Kittas C, Mykoniatis M, et al. Effect of cadmium pretreatment on liver regeneration after partial hepatectomy in rats. Arch Toxicol 1994;68:85–90.
   PubMedGoogle Scholar
• He F, Wu C, Tu Q, Xing G. Human hepatic stimulator substance: a product of gene expression of human fetal liver tissue. Hepatology 1993;17:225–9.
   PubMedGoogle Scholar